A Study To Evaluate The Safety And Efficacy Of PF-06826647 In Participants With Moderate To Severe Ulcerative Colitis

Status:
Withdrawn

Trial end date:
2023-10-26

Target enrollment:

Participant gender:

The purpose of this study is to evaluate efficacy and safety of PF-06826647 in moderate to severe ulcerative colitis

Phase 2

Pfizer